News

Virtune's Monthly Rebalancing Update for Crypto Index ETP

Virtune's Monthly Rebalancing Update for Crypto Index ETP

Virtune's Latest Monthly Rebalancing Results

Virtune AB (Publ) has successfully completed its monthly rebalancing of the Virtune Crypto Top 10 Index ETP, a pioneering product in the Nordic region that offers exposure to the top cryptocurrencies based on market capitalization.

Understanding the Virtune Crypto Top 10 Index ETP

This innovative ETP, listed on Nasdaq Stockholm under two different denominations, allows investors to access a basket of leading cryptocurrencies without the high risk of single-asset investments. The SEK-denominated ETP is identified by the ISIN code SE0020052207 and ticker name VIR10SEK, while the EUR-denominated counterpart is assigned ISIN SE0020052215 and ticker VIR10EUR.

Current Index Allocation

As of the end of June, the index underwent a rebalance which adjusted the allocations of its constituent assets. Prior to rebalancing, Bitcoin held a significant weight of 42.02%, followed closely by Ethereum at 30.73%. Other assets included XRP, Solana, Cardano, and several others, with varying percentages contributing to the overall index.

Allocation Before Rebalancing

Before the rebalance, the allocations were as follows: Bitcoin: 42.02%, Ethereum: 30.73%, XRP: 13.36%, Solana: 8.21%, and other assets such as Cardano and Chainlink holding much smaller percentages.

Allocation After Rebalancing

Post-rebalancing, these allocations shifted slightly. Bitcoin was decreased to 40.00%, whereas Ethereum was adjusted to 32.33%. Interestingly, while the top two assets experienced a change in their weightings, the lower-ranking assets such as Chainlink and Avalanche maintained their positions, with Avalanche witnessing a significant drop in value.

Market Performance Insights

The performance of the top cryptocurrencies in June was mixed, with Uniswap leading the pack demonstrating growth of 17.8%. Following Uniswap were XRP and Bitcoin, both of which experienced positive returns. Unfortunately, Ethereum and several other assets reported declines, reflecting the volatile nature of the crypto market.

Top Performers

Top performers included Uniswap with a 17.8% increase, XRP at 2.95%, and Bitcoin rising by 2.40%. This showcases the significant variance in asset performance, highlighting the need for diverse investment strategies in the cryptocurrency ecosystem.

Bottom Performers

Conversely, Avalanche and Cardano faced considerable losses of -13.7% and -16.6%, respectively. Such fluctuations emphasize the inherent volatility and the necessity for strategic rebalancing within the index.

Opportunities for Investors

For institutional investors interested in capitalizing on this evolving asset class, Virtune provides an array of cryptocurrency products that cater to diverse investment strategies. Engaging with Virtune can unveil numerous opportunities for asset managers looking to enhance their offering with innovative ETPs.

Contact and Further Information

If you are keen on learning more about Virtune's offerings and how these ETPs can integrate into broader asset management strategies, reach out to us. Our team is always eager to discuss new opportunities for investors keen to explore this dynamic market.

Frequently Asked Questions

What is the Virtune Crypto Top 10 Index ETP?

The Virtune Crypto Top 10 Index ETP is an investment product that tracks the performance of the top ten cryptocurrencies based on market capitalization.

How often does Virtune rebalance its Crypto Index ETP?

Virtune rebalances its Crypto Index ETP on a monthly basis to reflect current market conditions and manage asset volatility.

What assets are included in the Virtune Crypto Top 10 Index?

The index includes major cryptocurrencies like Bitcoin, Ethereum, XRP, Solana, and others, ensuring broad market exposure.

How can I invest in Virtune's Crypto ETPs?

Investors can purchase Virtune's ETPs through their stock broker, similar to buying shares of a company.

Who can I contact for more information?

For inquiries, you can contact Christopher Kock, CEO of Virtune AB, via email at Christopher@virtune.com or by phone at +46 70 073 45 64.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Beverly Hills MD's Dermal Cream Wins Key Beauty Award

Updated Category News Views 2

A Surprise Win in the Beauty World Who doesn't love an underdog story, right? Beverly Hills MD has slid into the limelight with their Dermal Repair Complex snagging the award for 'Beauty Product of the Year.' Talk about sending shockwaves through the beauty industry! Now, these guys might not be a household name yet, but you better believe they've got everyone's attention...

Continue Reading
Curaleaf Expands in Florida Amid Rising Cannabis Demand

Updated Category News Views 1

Curaleaf's Bold Moves in Florida's Ganja Gold Rush Fresh out of the gate, Curaleaf is saddling up for a wild ride into Florida's cannabis frontier. They've just thrown open the doors of their latest dispensary in Riverview, cranking their statewide count up to 77. Now, isn’t that something? If you're tracking these folks, you know that bringing their nationwide total to...

Continue Reading
AI Platform Suno Sued for Exploiting Artists' Identities

Updated Category News Views 1

AI and the Music Business: A Legal Storm Brews Well, it looks like the music world’s hitting a rough patch with AI in the crosshairs. We've got Korein Tillery, a heavyweight in the legal arena, throwing down the gauntlet against Suno, an AI music-generation platform. Folks, welcome to the battleground where art meets tech and identity theft takes a whole new meaning....

Continue Reading
Rackspace Lawsuit Deadline: Investors Must Take Action

Updated Category News Views 2

Rackspace's Legal Predicament: Time for Action Alright folks, if you're holding shares of Rackspace Technology (NASDAQ:RXT), it’s time to sit up and pay attention. This is about more than bad PR or a temporary hiccup in the stock price—this is serious business. We’ve got until September 28, 2026, to decide if we’re in or out on this class action lawsuit train....

Continue Reading
Clinical Trials Services Market Set for Big Growth

Updated Category News Views 0

Eyeing a Market Surge in Clinical Trials Numbers don't lie, and they're painting a promising picture for the clinical trials services market with a solid 8% growth forecasted annually till 2031. From a modest $66.20 billion in 2026, we're looking at ballooning to a hefty $97.41 billion by 2031. What’s cooking? Let me dish it out for you. Key Drivers and Dynamics North...

Continue Reading
Art and Science Blend in Dr. De La Cruz's Approach

Updated Category News Views 2

Redefining Aesthetic Surgery: An Artistic Approach The world of plastic surgery is often seen through the lens of beauty and symmetry, but for Dr. Emmanuel De La Cruz, it's like staring into a whole different universe. This Houston-based plastic surgeon isn't just removing fat—he's reshaping the human canvas with the eye of a sculptor. Beyond the Standard Cut and Snip...

Continue Reading
IVD Study Success: Hybrid Monitoring Boosts Oversight

Updated Category News Views 1

New Strategies for IVD Clinical Studies It's high time we addressed the tangled web of managing in vitro diagnostic (IVD) clinical studies. We're talking about walking a tightrope where sponsors have to juggle regulatory scrutiny, data integrity, and operational efficiency—all while pushing innovation. Simply put, the old ways of doing things just aren't cutting it...

Continue Reading
CAPR Faces Lawsuit and FDA Delay: Investor Alert

Updated Category News Views 1

Trouble Brewin' for Capricor Investors Buckle up, folks. Capricor Therapeutics (NASDAQ: CAPR) is caught in a storm, facing not just the lengthy arm of law with a securities class action, but also a seemingly endless wait with the FDA's decision on their lead product. We're talking serious implications for anyone with skin in the game. The FDA's Delayed Blessing So the...

Continue Reading
Orbis Celebrates 20 Years of Eye Care in Macau

Updated Category News Views 2

Celebrating Two Decades of Eye Health Innovation Orbis, a name synonymous with eye care worldwide, has hit a remarkable milestone. Celebrating two decades of commitment to eye health in Macau, they've rolled out their Flying Eye Hospital with a mission of profound impact. This isn't just about a fancy airplane; it’s about real, lasting change through training projects...

Continue Reading
Faruqi & Faruqi Urge Wix Investors to Act Now

Updated Category News Views 3

Ticking Clock for Wix Investors' Legal Moves The buzz in the stock market is louder than a bull on Wall Street, especially if you're tangled up with Wix.com Ltd. (NASDAQ: WIX). We've got Faruqi & Faruqi, LLP laying down serious advice: move fast or maybe lose your spot in line. The deadline to noodle over your position as a lead plaintiff in their federal securities class...

Continue Reading

Top 5 Most Recently Viewed Articles

Executive Shifts at Title Resources Group: Key Leadership Updates

Updated Category News Views 233

Leadership Changes at Title Resources Group Title Resources Group (TRG), a leading title insurance underwriter, is undergoing an important executive transition. Kevin Wall is set to be appointed as the new Chief Executive Officer (CEO), succeeding J. Scott McCall, who will transition to the role of Vice Chairman of the Board of Directors. This strategic move, reflecting...

Continue Reading
Bear Stewart Recall: Soy Allergy Alert Shakes Confidence

Updated Category News Views 56

Undeclared Ingredients: Not Just Another Casual Glitch Well, here we go again. Bear Stewart LLC's latest revelation sends alarm bells ringing for anyone with a nose for allergic disorders. Their Bakr Brown Butter Chocolate Chunk Ready To Bake Cookie Dough found its way to store shelves with an ingredient that can cause mayhem for many – soy. Imagine thinking you’re...

Continue Reading
Exploring the Impact of Inclusivity in Global Advertising

Updated Category News Views 134

The Importance of Inclusive Advertising In today's dynamic advertising landscape, inclusivity plays a critical role in how brands connect with their audiences. Inclusivity isn't just a buzzword; it's becoming essential for brands aiming to resonate with diverse demographics, reflecting the world we live in. XR Extreme Reach, a leading global technology company, has taken...

Continue Reading
Suburban Propane Partners with Local Organizations for Community Support

Updated Category News Views 117

Suburban Propane's Commitment to Community Well-being Suburban Propane Partners, L.P. (NYSE: SPH), a leading provider of propane and renewable energy solutions, is dedicated to making a positive impact in local communities. Recently, they partnered with Sharing House, a community organization focused on assisting those in need. This collaboration aimed to gather essential...

Continue Reading
GoHealth Inc. Achieves New Heights with Stock Performance

Updated Category News Views 227

GoHealth's Significant Stock Surge Recently, GoHealth Inc. (GOCO) has made headlines as it reached a remarkable milestone by hitting a 52-week high of $14.94. This achievement illustrates a substantial 12% gain over the past week and a phenomenal 40% surge over the last six months. Investors and market analysts have been captivated by these developments, considering the...

Continue Reading